Financial News
Enveric Biosciences Inc (NQ: ENVB )
0.5350
+0.0038
(+0.72%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Enveric Biosciences Inc
![](https://mms.businesswire.com/media/20240813429920/en/2214388/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240812797182/en/2214062/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240725903859/en/2196252/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240715938433/en/2185676/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240710300771/en/2181789/22/Enveric.jpg)
From Enveric Biosciences
Via Business Wire
![](https://mms.businesswire.com/media/20240625428098/en/2168894/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240529455789/en/2145271/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240514374351/en/2131630/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240514809396/en/2129050/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240508099100/en/2123993/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240326297550/en/2080198/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240318068312/en/2071967/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240311029002/en/2063553/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240228697980/en/2049712/22/Enveric_logo.jpg)
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB
February 28, 2024
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://mms.businesswire.com/media/20240222887102/en/2043384/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20240221498747/en/2039758/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240103821215/en/1986545/22/Enveric.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20231228071292/en/1981568/22/Enveric.jpg)
From Enveric Biosciences
Via Business Wire
![](https://mms.businesswire.com/media/20231227487990/en/1980494/22/Enveric.jpg)
![](https://www.marketbeat.com/logos/articles/med_20231220075859_biotech-stocks-tapping-into-unmet-mental-health-tr.jpg)
![](https://mms.businesswire.com/media/20231220008475/en/1975196/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20231205577387/en/1960416/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231128128606/en/1954928/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231126422057/en/1952611/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231123642251/en/1952144/22/Enveric_logo.jpg)
![](https://mms.businesswire.com/media/20231113261127/en/1943584/22/Enveric_logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20231020004309/en/1921129/22/Enveric_logo.jpg)
From Enveric Biosciences
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.